InvestorsHub Logo
Post# of 252998
Next 10
Followers 22
Posts 3688
Boards Moderated 0
Alias Born 07/20/2006

Re: faxedreceipts post# 236290

Wednesday, 12/16/2020 4:41:37 PM

Wednesday, December 16, 2020 4:41:37 PM

Post# of 252998
AbbVie unit wins ITC trade secret case against Evolus

AbbVie's (ABBV) Allergan unit won an order to block Evolus (EOLS) and partner Daewoong from importing Jeuveau into the U.S. for 21 months, reported Bloomberg's Susan Decker and Christopher Yasiejko. Jeuveau is a rival to Allergan's wrinkle treatment Botox. Following the report, Evolus shares are down 46c, or 11%, to $3.57 in afternoon trading.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.